1 Introduction 6

• 1.1 Industry Definition and Research Scope 6
  • 1.1.1 Industry Definition 6
  • 1.1.2 Research Scope 7
• 1.2 Research Methodology 9
  • 1.2.1 Overview of Market Research Methodology 9
  • 1.2.2 Market Assumption 10
  • 1.2.3 Secondary Data 10
  • 1.2.4 Primary Data 10
  • 1.2.5 Data Filtration and Model Design 11
  • 1.2.6 Market Size/Share Estimation 12
  • 1.2.7 Research Limitations 13
• 1.3 Executive Summary 14

2 Market Overview and Dynamics 16

• 2.1 Market Size and Forecast 16
• 2.2 Major Growth Drivers 17
• 2.3 Market Restraints and Challenges 20
• 2.4 Emerging Opportunities and Market Trends 23
• 2.5 Porter’s Fiver Forces Analysis 26

3 Segmentation of Europe Market by Product Type 30

• 3.1 Market Overview by Product Type 30
• 3.2 Fixation Devices 33
  • 3.2.1 Tack 34
  • 3.2.2 Staple 35
  • 3.2.3 Suture 36
  • 3.2.3 Glue 37
• 3.3 Consumables (Mesh) 38
  • 3.3.1 Biological Mesh 39
  • 3.3.2 Synthetic Mesh 40

4 Segmentation of Europe Market by Surgery Type 42

• 4.1 Market Overview by Surgery Type 42
• 4.2 Open-Tension Free Repair 44
• 4.3 Laparoscopic Tension Free Repair 45
• 4.4 Tension Repair 46
• 4.5 Robotic-Assisted Hernia Repair 47

5 Segmentation of Europe Market by Hernia Type 48

• 5.1 Market Overview by Hernia Type 48
• 5.2 Umbilical 50
• 5.3 Incisional 51
• 5.4 Femoral 52
• 5.5 Inguinal 53
• 5.6 Paraumbilical 54
• 5.7 Epigastric 55
• 5.8 Other Hernia Types 56

6 Segmentation of Europe Market by End-user 57

• 6.1 Market Overview by End-user 57
• 6.2 Ambulatory Surgical Centers 59
• 6.3 Clinics 60
• 6.4 Hospitals 61

7 European Market 2019-2026 by Country 62

• 7.1 Overview of European Market 62
• 7.2 Germany 65
• 7.3 UK 67
• 7.4 France 69
• 7.5 Spain 71
• 7.6 Italy 73
• 7.7 Rest of European Market 75

8 Competitive Landscape 77

• 8.1 Overview of Key Vendors 77
• 8.2 New Product Launch, Partnership, Investment, and M&A 81
• 8.3 Company Profiles 83

Becton, Dickinson And Company 83

B. Braun Melsungen AG 85

Baxter International, Inc. 86

C.R. Bard, Inc. 87

Cook Medical, Inc. 88

Cousin Biotech 89

Duomed Group 90

Ethicon, Inc. (Johnson & Johnson) 91

Getinge AB 92

Herniamesh S.r.l. 93

Integra Lifesciences Holding Corp. 94

LifeCell Corp. (Allergan) 95

MAQUET Holding B.V. & Co. KG. 96

Medline Industries, Inc. 97

Medtronic PLC. 98

Olympus Corp. 99

The Cooper Companies, Inc. 100

TransEasy Medical Tech. Co., Ltd. 101

Via Surgical Ltd. 102

W. L. Gore & Associates, Inc. 103

9 Investing in Europe Market: Risk Assessment and Management 104

• 9.1 Risk Evaluation of Europe Market 104
• 9.2 Critical Success Factors (CSFs) 107

Related Reports and Products 110

Europe hernia repair market reached $1,102.1 million in 2019 and will grow by 4.3% over 2020-2026 owing to the rising hernia diseases and need for hernia repair in the region.
Highlighted with 36 tables and 46 figures, this 110-page report “Europe Hernia Repair Market 2020-2026 by Product Type, Surgery Type, Hernia Type, End-user, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe hernia repair market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Europe hernia repair market in every aspect of the classification from perspectives of Product Type, Surgery Type, Hernia Type, End-user, and Country.
Based on product type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Fixation Devices (further segmented into Tack (split into Absorbable Tack and Non-absorbable Tack), Staple, Suture, Glue)
• Consumables (Mesh) (further segmented into Biological Mesh and Synthetic Mesh (further split into Absorbable Mesh and Non-Absorbable Mesh; Flat Mesh and 3D Mesh))
Based on surgery type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Open-Tension Free Repair
• Laparoscopic Tension Free Repair
• Tension Repair
• Robotic-Assisted Hernia Repair
Based on hernia type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Umbilical
• Incisional
• Femoral
• Inguinal
• Paraumbilical
• Epigastric
• Others
Based on end user, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Ambulatory Surgical Centers
• Clinics
• Hospitals
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe (further segmented into Russia, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Surgery Type, and End-user over the study years (2019-2026) is included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe hernia repair market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players:
Becton, Dickinson And Company
B. Braun Melsungen AG
Baxter International, Inc.
C.R. Bard, Inc.
Cook Medical, Inc.
Cousin Biotech
Duomed Group
Ethicon, Inc. (Johnson & Johnson)
Getinge AB
Herniamesh S.r.l.
Integra Lifesciences Holding Corp.
LifeCell Corp. (Allergan)
MAQUET Holding B.V. & Co. KG.
Medline Industries, Inc.
Medtronic PLC.
Olympus Corp.
The Cooper Companies, Inc.
TransEasy Medical Tech. Co., Ltd.
Via Surgical Ltd.
W. L. Gore & Associates, Inc.
(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)